ZNOG Archives - Page 5 of 5 - Blue Horseshoe Stocks

TBIO Options Update & More

Translate Bio, Inc. TBIO – Update:

We were just mentioning our successful MRNA calls from Monday morning in yesterday’s report. In that same report to kick off this week, we also formulated an extended-term options idea on TBIO. After some solid sessions have gone on the books this week, we’re swinging back around to check into our total possible gains.

We targeted the TBIO 08/20 $17.50-20 Calls, and on the strength of the stock running from 18.02-22.49 (+25%) over the span of the past three sessions, we have seen some pretty solid runs.

Here are the trading ranges and total possible gains that were made available by these TBIO Calls:

TBIO 08/20 $17.50-20 Calls
$65: 2.88-5.20 (+81%)
$70: 1.65-4.00 (+142%)

Meanwhile, with plenty of time remaining until expiration and plenty of upside potential on the TBIO chart, we’ll continue to track these targets in the days and weeks ahead.

Fresh Options Ideas:
CCIV Weekly $25-26 Calls
DRI 07/16 $140-145 Calls
ACN Weekly $292.50-297.50 Calls
EXPI 07/16 $40 Calls

Extended Watchlist:
ZNOG, BSSP, ADSV, MRIN, ARAV, GTT, IGC, EVIO, PRPM

Form-4 Bottom Play & More

SPDR S&P500 (ETF) SPY
–
We are still actively tracking the options targets we designated in the SPY chain in Tuesday’s premarket report which were the SPY Weekly $340-341 Calls. We got some pretty nice intraday gain opportunities in the 60-80% range early Tuesday, but the following upswing that we observed in these plays yesterday was far better.

The $340 Calls registered another run from .98-3.28, which marks a 235% move, while the $341’s ran from .75-2.65, for a 253% rip.
_____

Fresh Options Idea:
DPZ Weekly $427.50-417.50 Puts

Arcutis Biotherapeutics Inc. ARQT – Form-4 Bottom Bouncer

Following multiple Form-4 submissions to the tune of over $12M each last week, ARQT sold off and began to establish just the type of chart setup we are always on the lookout for. A recently tanked stock with a gap on the chart to the upside, that is establishing a trend off of that bottom.

Combined with the recent insider purchases, and it makes for a stock that we need to have on our watchlist in the weeks, and perhaps even months ahead.

Extended Watchlist:
ALYI, ABMC, AREC, DMDD, NUVI, ZNOG

Options Success, Bottom Watch Play

SPY Options Review

Yesterday morning, we went bearish on the markets as a whole, signaling the SPY 09/09 $340-338 Puts for observation in our premarket report. Our hunch on the daily direction of the wind proved solid, as the contracts in our designated range produced healthy intraday runs.

Here are the moves and total possible gains we witnessed there:

SPY 09/09 $340-338 Puts
$340: 3.94-7.59 (+93%)
$339: 3.30-6.78 (+105%)
$338: 2.75-6.00 (+118%)
_____

Fresh Options Ideas:
KOD 10/16 $45-50 Calls
LULU Weekly $340-335 Puts

Akabia Therapeutics, Inc. AKBA

We took notice of AKBA this morning because of the intriguing setup of the chart. The company had a bad clinical report recently and fell off of an absolute cliff. We want to place this on bottom watch and observe closely over the next several sessions.

There is a massive gap to the upside that you could drive a truck through, so we’re going to be anxious to see when the stock will move to fill some of that gap.

Extended Watchlist:
NKLA, SPCE, CODX, BASA, ZNOG, IJJP